Search - tctmd.com

Displaying 181 - 200 of 645

Sort: Relevancy | Date

Presentation TVT 2021

How Has the Watchman FLX Improved Outcomes vs Watchman 2.5?

Presenter: Brijeshwar Maini

July 22, 2021

Presentation TVT 2021

Three Cases of Challenging Anatomy for Left Atrial Appendage Closure

Presenter: Sameer Gafoor

July 22, 2021

Presentation TVT 2021

Using Imaging Guidance for Optimal TS Location and Guide Catheter Shape

Presenter: Matthew Price

July 22, 2021

Presentation TVT 2021

High Success and Low Complications of LAAO: Should All AF Patients Having Transcatheter Procedures Be Offered LAAO?

Presenter: Saibal Kar

July 22, 2021

Presentation TVT 2021

What Are the New LAAO Devices and What Problems Are They Solving

Presenter: Megan Coylewright

July 22, 2021

Presentation TVT 2021

How to Create an LAAO Program: From Physician Competency to Patient Education

Presenter: Shephal Doshi

July 22, 2021

Presentation TVT 2021

Clinical Data Refresh: What's New in LAAO

Presenter: Vivek Reddy

July 22, 2021

Presentation TVT 2021

PFO Closure and Atrial Fibrillation

Presenter: Robert Sommer

July 22, 2021

Presentation TVT 2021

Long-term Data Updates on RCTs in PFO Closure

Presenter: John Rhodes

July 22, 2021

Presentation TVT 2021

PFO Closure in Non-Stroke Patients

Presenter: Brian Whisenant

July 22, 2021

Presentation TVT 2021

PFO Closure for Stroke: When Should We Consider Patients Over 60 Years of Age?

Presenter: Megan Coylewright

July 22, 2021

Presentation TVT 2021

When Both Silent AF and PFO Are Discovered During a Cryptogenic Stroke Work-up, the Optimal Therapy to Prevent Stroke Recurrence Is…

Presenter: Mark Reisman

July 22, 2021

Presentation TVT 2021

With a Hypercoagulable Condition: Is PFO Closure More Important, More Dangerous, or Both?

Presenter: Julia Seeger

July 22, 2021

Presentation TVT 2021

How to Work Around/Through PFO Devices for LAAO/Mitraclip and Other Left Sided Procedures

Presenter: Tara Jones

July 22, 2021

Presentation TVT 2021

Do We Need a NOAC vs PFO Closure Trial?

Presenter: John Carroll

July 22, 2021

Presentation TVT 2021

PFO Device Evolution: Do We Need to Reduce the Anatomical Footprint?

Presenter: Horst Sievert

July 22, 2021

Presentation TVT 2021

PFO and Migraine: Isolating a Cohort

Presenter: Robert Sommer

July 22, 2021

Presentation TVT 2021

Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System for Severe Tricuspid Regurgitation: A Multicenter, First-in-Human 1-Year Observation

Presenter: Ming-yu (Anthony) Chuang

July 21, 2021

Presentation TVT 2021

First Commercial Multicenter Experience With the PASCAL Transcatheter Valve Repair System for Tricuspid Regurgitation

Presenter: Jörg Hausleiter

July 21, 2021

Presentation TVT 2021

First Report of 2-Year Outcomes With a Next-Generation Left Atrial Appendage Closure Device: Final Results From the PINNACLE FLX IDE Trial

Presenter: Saibal Kar

July 21, 2021

Advertisement

How Has the Watchman FLX Improved Outcomes vs Watchman 2.5?

Three Cases of Challenging Anatomy for Left Atrial Appendage Closure

Using Imaging Guidance for Optimal TS Location and Guide Catheter Shape

High Success and Low Complications of LAAO: Should All AF Patients Having Transcatheter Procedures Be Offered LAAO?

What Are the New LAAO Devices and What Problems Are They Solving

How to Create an LAAO Program: From Physician Competency to Patient Education

Clinical Data Refresh: What's New in LAAO

PFO Closure and Atrial Fibrillation

Long-term Data Updates on RCTs in PFO Closure

PFO Closure in Non-Stroke Patients

PFO Closure for Stroke: When Should We Consider Patients Over 60 Years of Age?

When Both Silent AF and PFO Are Discovered During a Cryptogenic Stroke Work-up, the Optimal Therapy to Prevent Stroke Recurrence Is…

With a Hypercoagulable Condition: Is PFO Closure More Important, More Dangerous, or Both?

How to Work Around/Through PFO Devices for LAAO/Mitraclip and Other Left Sided Procedures

Do We Need a NOAC vs PFO Closure Trial?

PFO Device Evolution: Do We Need to Reduce the Anatomical Footprint?

PFO and Migraine: Isolating a Cohort

Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System for Severe Tricuspid Regurgitation: A Multicenter, First-in-Human 1-Year Observation

First Commercial Multicenter Experience With the PASCAL Transcatheter Valve Repair System for Tricuspid Regurgitation

First Report of 2-Year Outcomes With a Next-Generation Left Atrial Appendage Closure Device: Final Results From the PINNACLE FLX IDE Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content